SCHEMBL7206809

SCHEMBL7206809

CCCCCN(C)CCCCCCO[C@H]1CC[C@H](N(Cc2ccccc2)C(=O)OCc2ccccc2)CC1

nearest known ligand 0.42

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 4/20 0.41
CCR5 P51681 3/20 0.41
TP53 P04637 1/20 0.41
LTA4H P09960 2/20 0.40
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
ALDH1A1 P00352 1/20 0.39
CYP3A4 P08684 1/20 0.39
TSHR P16473 1/20 0.39
MAPK1 P28482 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
PTGDR2 Q9Y5Y4 1/20 0.38
OPRM1 P35372 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7206805 1.00 HTR2A (0.41) HTR2ACCR5TP53LTA4HMEN1
SCHEMBL7210228 0.93 CCR5 (0.44) CCR5LTA4HALDH1A1CYP3A4TSHR
SCHEMBL7210226 0.93 CCR5 (0.44) CCR5LTA4HALDH1A1CYP3A4TSHR
SCHEMBL4806102 0.93 HTR2A (0.39) HTR2ALTA4HMEN1KMT2AL3MBTL1
SCHEMBL4806095 0.93 HTR2A (0.39) HTR2ALTA4HMEN1KMT2AL3MBTL1
SCHEMBL4801914 0.92 PTGDR2 (0.40) HTR2ALTA4HMEN1KMT2APTGDR2
SCHEMBL4801905 0.92 PTGDR2 (0.40) HTR2ALTA4HMEN1KMT2APTGDR2
SCHEMBL7206162 0.91 CCR5 (0.43) HTR2ACCR5LTA4HALDH1A1CYP3A4
SCHEMBL7206156 0.91 CCR5 (0.43) HTR2ACCR5LTA4HALDH1A1CYP3A4
SCHEMBL4806532 0.90 SIGMAR1 (0.42) HTR2ACCR5L3MBTL1PTGDR2OPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1311475-A1 NOVEL AMINOCYCLOHEXANE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2003-05-21 EP disclosed
WO-2002014267-A1 NOVEL AMINOCYCLOHEXANE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2002-02-21 WO disclosed